ProCE Banner Activity

The Shifting Treatment Paradigm for Initial Clostridioides difficile Infection (CDI)

Clinical Thought
Understanding the role of treatment goals for initial CDI is critical. Heres what this means for you.

Released: March 10, 2022

Expiration: March 09, 2023

No longer available for credit.

Share

Faculty

Kevin Garey

Kevin Garey, PharmD, MS

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Houston, Texas

Provided by

ProCE Banner

Supporters

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Kevin Garey, PharmD, MS

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Houston, Texas

Kevin Garey, PharmD, MS, has disclosed that he has received contracted research support from Acurx, Paratek, Seres, and Summit.